Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
CVS Health is a major US healthcare company. It runs thousands of pharmacies, the health insurer Aetna and, with Caremark, a pharmacy benefit manager. It also operates doctors’ offices and primary care. As of Oct 13, 2026
As of Oct 13, 2026Fact sheet (from the annual report)Pharmacies and drugstores · Woonsocket, USAfull fact sheet
The group offers health insurance, manages pharmacy benefits, runs stores and clinics and reports in the segments Health Care Benefits and Health Services, among others. Under the Aetna name, the insurance segment offers medical, dental and behavioral health plans as well as plans for the government programs Medicare and Medicaid. Members are insured mainly through employers, government programs or individually; sales run through its own employees as well as brokers, agents and consultants. Under CVS Caremark, the Health Services segment manages pharmacy benefits mainly for employers, insurers, unions and health plans, including mail-order and specialty pharmacies. This segment also includes the Oak Street Health primary care centers for members in the Medicare program as well as Signify Health.
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Detected chart patterns
Warning pattern Head and shoulders on the daily chart, detected on Nov 4, 2026
Free with an account until Jan 31, 2027: all Premium features, no subscription and no card. Sign up free
Earlier patterns · Past performance, not a forecast
Earlier patternsChart patterns that were detected for this asset earlier, each with its outcome: target 1 reached, stop reached (invalid), time limit over or still open. A list of the past, not a forecast.Example: Example: “Flag, detected on 3 Sep, target 1 reached on 22 Sep” – describes that one case, not the next pattern.More in the Academy: Glossary
Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure
1Wweekly candles↔ mixed
Close above the SMA 200
EMA 20 above the EMA 50
lower highs and lower lows
Price below the EMA 20 · below the EMA 50
Week to Nov 20, 2026
1Ddaily candles↘ down
Close below the SMA 200
EMA 20 below the EMA 50
lower highs and lower lows
Price below the EMA 20 · below the EMA 50
Daily candle of Nov 20, 2026
4H4-hour candles↔ mixed
Close below the SMA 200
EMA 20 below the EMA 50
Highs and lows mixed
Price below the EMA 20 · below the EMA 50
Candle from Nov 20, 2026, 19:30
Rule per timeframe: up = close above the SMA 200, EMA 20 above the EMA 50 and higher highs and lows; down = everything the other way round; otherwise mixed. Completed candles only, no overall score, no forecast. In the screener: all three up →
What does the daily chart show right now – line by line, without an overall verdict?
Technicals in plain words
Technicals in plain wordsFour lines on the daily chart – trend, momentum, volume, volatility –, each with its metric and threshold. We do not add the lines up or give a grade; they describe the price history so far.Example: RSI 64 → between 30 and 70, neither overbought nor oversold.More in the Academy: Lesson reading the RSI
Over the last 3 months it ran weaker than the S&P 500 and weaker than the median of the sector “Health Care”.
vs. S&P 500 · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
weaker
vs. S&P 500 · 6 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
weaker
vs. sector · 3 monthsRelative strengthA stock’s price change minus that of the benchmark over the same period, in percentage points: against the S&P 500 (ETF SPY) or the median of its sector, over 3 or 6 months. Above 0 it ran stronger, below 0 weaker – this describes the past.Example: Stock +12%, S&P 500 +5% in 3 months → +7 percentage points, ran stronger.More in the Academy: Lesson relative strength
weaker
Trendbelow SMA 200Price below the 200-day line – below it the long-term trend counts as down; ADX between 20 and 25 – a moderate trend.
MomentumneutralRSI between 30 and 70 – neither overbought nor oversold; MACD line fell below its signal line in the last 5 trading days.
Volumenot elevatedVolume on the last trading day below 1.5 times the average of up to 50 trading days before – not elevated.
VolatilitynormalTypical daily range (ATR 14) between 2 and 4% of the price – normal.
The figures behind it – distance to the line, RSI, volume, volatility and relative strength in percentage points – are visible with a free account.Sign up free
More depth
How we read the lines
Each line stands on its own – we do not add them up and give no grade.
Trend: the 200-day line is the average of the last 200 closing prices. The ADX (14) measures how pronounced a trend is, not its direction: below 20 hardly any trend, above 25 pronounced.
Momentum: the RSI (14) lies between 0 and 100; below 30 it counts as oversold, above 70 as overbought. The MACD (12/26) compares two averages, the signal line (9) smooths it.
Volume: shares traded on the last trading day divided by the average of up to 50 trading days before; from 1.5x elevated, from 2x unusually high, from 3x very high.
Volatility: typical daily range (ATR 14) as a percentage of the price; below 2% calm, 2 to 4% normal, above 4% high. Squeeze = Bollinger Bands as narrow as on at most a fifth of the last 120 trading days.
Relative strength: the stock’s price change minus that of the benchmark over the same period (3 months = 91 days, 6 months = 182 days), in percentage points, from completed daily candles. Benchmark: the S&P 500 (ETF SPY) or the median of the stocks of the same sector in our selection (at least 5 others with a candle on the same day). Dividends are not included.
Against the sector median over 6 months: ran weaker.
All figures describe the price history so far – they do not say what happens next.
As of: daily candle of Nov 20, 2026 · from our daily candles
How did this asset do in each calendar month over the last 10 years?
Seasonality
SeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
In November, the stock closed higher in 7 of 10 years – the S&P 500 in 9 of 10.
Years higher in NovemberSeasonalityHow an asset did in each calendar month over the last 10 years: monthly return from the last trading day of the previous month to the last one of the month, without dividends, completed months only. Past performance, not a forecast.Example: Example: November higher in 7 of 10 years → describes past years, not the next November.More in the Academy: Lesson seasonality
7 of 10
2016 to 2025
S&P 500 in November
9 of 10
years higher, same years as above (ETF SPY)
Months mostly higher
5 of 12
Calendar months that closed higher in more than half of the years
You can see the median and range per month in percent with a free account.Sign up free
4/10Jan
3/10Feb
4/10Mar
6/10Apr
4/10May
6/10Jun
6/10Jul
5/10Aug
6/10Sep
4/10Oct
7/10Nov
4/10Dec
January: higher in 4 of 10 years
February: higher in 3 of 10 years
March: higher in 4 of 10 years
April: higher in 6 of 10 years
May: higher in 4 of 10 years
June: higher in 6 of 10 years
July: higher in 6 of 10 years
August: higher in 5 of 10 years
September: higher in 6 of 10 years
October: higher in 4 of 10 years
November (current month): higher in 7 of 10 years
December: higher in 4 of 10 years
Past performance, not a forecast · Bar = share of years higher, line = half · Price return without dividendsMore depth
How we calculate
Monthly return = closing price on the last trading day of the month ÷ closing price on the last trading day of the previous month − 1. Price return without dividends.
Only completed months count, never the current one. If the candle of the last trading day is missing, the month does not count.
For each calendar month the last 10 years in which it has ended; from 8 years with a value we show the median, years higher and the range. “Higher” means: return above 0.0%.
Past performance, not a forecast: the figures describe earlier years and do not tell how the next month will go.
By calendar month (● = current month)
Month
Years higher
January
4 of 10
February
3 of 10
March
4 of 10
April
6 of 10
May
4 of 10
June
6 of 10
July
6 of 10
August
5 of 10
September
6 of 10
October
4 of 10
November ●
7 of 10
December
4 of 10
Through October 2026 (last completed month) · from our daily candles
Opportunity at a glance CVS Health
There is no opportunity card on 1-hour candles: we calculate patterns, targets and supports on the 4H, daily and weekly charts.
What does this mean? The card sums up chart patterns, potential to target, risk to stop and supports of CVS Health on the 4H, daily and weekly charts – every figure with its timeframe.
Potential to target 1●● %hidden4-hour or daily chart
Risk to stop
●● %hidden
Reward/risk
● : 1hidden
Remaining potential: moved since detection and still open to target 1 – each in % with timeframe.
Potential to target on the weekly chart●● %hiddenWeekly chart
Invalid below (weekly close)
●● %hidden
Supports below
3
Supports below with distance in %, timeframe and number of tests (possible levels to add).
Trend Trend by timeframeFor each timeframe (week, day, 4 hours): up when the close is above the SMA 200, the EMA 20 above the EMA 50 and the structure shows higher highs and lows. Down the other way round, otherwise mixed. No score, no forecast.Example: Week up, day up, 4 hours mixed → not aligned.More in the Academy: Lesson trend and market structure4H↔ mixed1D↘ down1W↔ mixed
In favour0 · Against1Points without chart-pattern detail – you see every point with figure and date with a free account
You see all figures, supports, for and against, and similar stocks with a free account.Create a free account
Calculated automatically by fixed rules – not investment advice. How we analyze
Potential
This shows the distance from the last close to the pattern’s target mark – a distance, not a return. Next to it the risk to the stop, each with the timeframe the figure comes from.
Supports below
Under “Long term” you find price areas below the price where it has already turned several times – with distance in percent, timeframe and number of tests. They describe where the price found support before.
For · Against
Fixed rules collect facts that speak for or against the picture, each with its date. There is deliberately no total and no grade – you do the weighing yourself.
My plan
“My plan” remembers your holding period and a target level of your own and lets you know when the price reaches the entry area. That and all figures of the card are available with a free account.
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
CVS Health · Sector Health Care · amounts in USD
Source: SEC filings, As of Feb 10, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.3x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
–no data: Gross margin above 40%reported cost of revenue does not include the benefit costs (margin more than 15 percentage points above an operating margin below 10%, e.g. health insurers)
✗not met: Operating margin above 15%1.2%
✗not met: Net margin above 10%0.4%
✗not met: Return on equity above 15%2.4%
✗not met: Free cash flow margin above 10%1.9%
✓met: Profit in each of the last 5 fiscal years5 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✗not met: Equity ratio above 30%29.7%
Operating margin
1.2%Fiscal year 2025
All18weak
Rank 18 of 100: higher than 18% of 470 peers (All). weak.
Sector18weak
Rank 18 of 100: higher than 18% of 54 peers (Sector). weak.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
0.4%Fiscal year 2025
All14weak
Rank 14 of 100: higher than 14% of 584 peers (All). weak.
Sector12weak
Rank 12 of 100: higher than 12% of 63 peers (Sector). weak.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on equity
2.4%Fiscal year 2025
All16weak
Rank 16 of 100: higher than 16% of 544 peers (All). weak.
Sector12weak
Rank 12 of 100: higher than 12% of 54 peers (Sector). weak.
Median Health Care: 12.8%
Net income divided by equity at fiscal year end.
Return on assets
0.7%Fiscal year 2025 (total assets at year end)
All16weak
Rank 16 of 100: higher than 16% of 594 peers (All). weak.
Sector12weak
Rank 12 of 100: higher than 12% of 63 peers (Sector). weak.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
29.7%Fiscal year 2025
All39medium
Rank 39 of 100: higher than 39% of 595 peers (All). medium.
Sector29weak
Rank 29 of 100: higher than 29% of 63 peers (Sector). weak.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
1.9%Fiscal year 2025
All20weak
Rank 20 of 100: higher than 20% of 465 peers (All). weak.
Sector17weak
Rank 17 of 100: higher than 17% of 61 peers (Sector). weak.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
7.8B USDFiscal year 2025
Operating cash flow minus capital expenditure on property and equipment.
Growth 5 of 7 met
✓met: Over 3 years, revenue grew by more than 5% per year+7.6%
✓met: Over 5 years, revenue grew by more than 5% per year+8.4%
✓met: Over 10 years, revenue grew by more than 5% per year+10.1%
✗not met: Over 3 years, EPS grew by more than 5% per year−23.8%
✗not met: Over 5 years, EPS grew by more than 5% per year−23.9%
✓met: Revenue rose in at least 4 of the last 5 fiscal years5 of 5
✓met: Revenue rose in the last fiscal year+7.8%
Revenue growth 3 years
+7.6%per year
All58medium
Rank 58 of 100: higher than 58% of 578 peers (All). medium.
Sector64medium
Rank 64 of 100: higher than 64% of 62 peers (Sector). medium.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+8.4%per year
All48medium
Rank 48 of 100: higher than 48% of 549 peers (All). medium.
Sector53medium
Rank 53 of 100: higher than 53% of 60 peers (Sector). medium.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+10.1%per year
All71strong
Rank 71 of 100: higher than 71% of 412 peers (All). strong.
Sector59medium
Rank 59 of 100: higher than 59% of 50 peers (Sector). medium.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
−23.8%per year
All9weak
Rank 9 of 100: higher than 9% of 437 peers (All). weak.
Sector6weak
Rank 6 of 100: higher than 6% of 54 peers (Sector). weak.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
−23.9%per year
All2weak
Rank 2 of 100: higher than 2% of 399 peers (All). weak.
Sector3weak
Rank 3 of 100: higher than 3% of 47 peers (Sector). weak.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
−11.3%per year
All3weak
Rank 3 of 100: higher than 3% of 375 peers (All). weak.
Sector1weak
Rank 1 of 100: higher than 1% of 46 peers (Sector). weak.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 6 of 7 met
✓met: Pays a dividend2.66 USD
✗not met: Payout ratio at most 60% of earnings191%
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✓met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.never
✓met: Dividend per share higher than 5 years ago+5.9%
✓met: Free cash flow per share covers the dividend2.3x
✓met: Dividends paid over the last 5 years covered by free cash flow29% of free cash flow
Payout ratio
191%Fiscal year 2025
Dividend per share divided by earnings per share.
Dividend growth 5 years
+5.9%per year
All40medium
Rank 40 of 100: higher than 40% of 321 peers (All). medium.
Sector44medium
Rank 44 of 100: higher than 44% of 31 peers (Sector). medium.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
2.3xFiscal year 2025
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 5 of 6 met
✓met: Piotroski F-Score at least 7 of 97 of 9
✓met: Long-term debt no higher than equity0.80
✗not met: Current assets cover current liabilities0.84
✓met: Positive equity75.2B USD
✓met: In 5 years, share count up by at most 5%−3.3%
✓met: Free cash flow positive in the last fiscal year7.8B USD
Piotroski F-Score
7 of 9Fiscal year 2025
All69strong
Rank 69 of 100: higher than 69% of 310 peers (All). strong.
Sector65medium
Rank 65 of 100: higher than 65% of 47 peers (Sector). medium.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
0.80at fiscal year end
All39medium
Rank 39 of 100: lower than 39% of 486 peers (All). medium.
Sector27weak
Rank 27 of 100: lower than 27% of 50 peers (Sector). weak.
Median Health Care: 0.66
Long-term financial debt divided by equity.
Liquidity (current ratio)
0.84at fiscal year end
All17weak
Rank 17 of 100: higher than 17% of 513 peers (All). weak.
Sector6weak
Rank 6 of 100: higher than 6% of 63 peers (Sector). weak.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−3.3%in 5 years
All52medium
Rank 52 of 100: lower than 52% of 507 peers (All). medium.
Sector45medium
Rank 45 of 100: lower than 45% of 59 peers (Sector). medium.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✗not met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✓met: Liquidity (current assets / current liabilities) rose
✗not met: No additional shares (diluted share count did not rise)
✓met: Gross margin higher than the prior year
✓met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light yellow: Revenue grew over 5 years (+8.4% per year), more slowly than the sector median.
Light red: Net income (total) shrank over 5 years (−24.4% per year); per share −23.9% per year.
Light yellow: Net margin 0.4%, below the sector median (13.9%).
Light yellow: Debt higher than usual in the sector.
Light yellow: Profit in 9 of 10 fiscal years.
Light red: Dividend higher than earnings.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
0200B400B600B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 177.5B USD · Net income 5.3B USD · Net margin 3.0%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 184.8B USD · Net income 6.6B USD · Net margin 3.6%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 194.6B USD · Net income −594.0M USD · Net margin −0.3%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 256.8B USD · Net income 6.6B USD · Net margin 2.6%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 268.7B USD · Net income 7.2B USD · Net margin 2.7%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 292.1B USD · Net income 7.9B USD · Net margin 2.7%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 322.5B USD · Net income 4.1B USD · Net margin 1.3%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 357.8B USD · Net income 8.3B USD · Net margin 2.3%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 372.8B USD · Net income 4.6B USD · Net margin 1.2%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 402.1B USD · Net income 1.8B USD · Net margin 0.4%
Margin
3.0%3.6%−0.3%2.6%2.7%2.7%1.3%2.3%1.2%0.4%
RevenueNet incomeNet margin (below)in USD
050B100B150B
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 93.8B USD · Net income 2.0B USD · Net margin 2.2% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 88.4B USD · Net income 1.1B USD · Net margin 1.3%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 91.2B USD · Net income 1.8B USD · Net margin 1.9%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 95.4B USD · Net income 87.0M USD · Net margin 0.1%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 97.7B USD · Net income 1.6B USD · Net margin 1.7% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 94.6B USD · Net income 1.8B USD · Net margin 1.9%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 98.9B USD · Net income 1.0B USD · Net margin 1.0%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 102.9B USD · Net income −4.0B USD · Net margin −3.9%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 105.7B USD · Net income 2.9B USD · Net margin 2.8% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 100.4B USD · Net income 2.9B USD · Net margin 2.9%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 106.1B USD · Net income 3.0B USD · Net margin 2.8%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 108.4B USD · Net income 2.2B USD · Net margin 2.0%
Margin
2.2%1.3%1.9%0.1%1.7%1.9%1.0%−3.9%2.8%2.9%2.8%2.0%
Earnings per shareUSD per share
02.004.006.008.00
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 4.90 USD
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 6.44 USD
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share −0.57 USD
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 5.08 USD
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 5.46 USD
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 5.95 USD
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 3.14 USD
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 6.47 USD
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 3.66 USD
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 1.39 USD
Earnings per shareUSD per share
−4.00−2.0002.004.00
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share not reported separately for Q4
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 0.88 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share 1.41 USD
Dividend per sharePayout ratio (below)USD per share
01.002.003.00
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Dividend per share 1.70 USD · Payout ratio 34.7%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Dividend per share 2.00 USD · Payout ratio 31.1%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Dividend per share 2.00 USD · Payout ratio not available
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Dividend per share 2.00 USD · Payout ratio 39.4%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Dividend per share 2.00 USD · Payout ratio 36.6%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Dividend per share 2.00 USD · Payout ratio 33.6%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Dividend per share 2.20 USD · Payout ratio 70.1%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Dividend per share 2.42 USD · Payout ratio 37.4%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Dividend per share 2.66 USD · Payout ratio 72.7%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Dividend per share 2.66 USD · Payout ratio 191.4%
Ratio
35%31%39%37%34%70%37%73%191%
Dividend per sharePayout ratio (below)USD per share
00.200.400.600.80
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 0.61 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 0.67 USD · Payout ratio 75.6%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 0.67 USD · Payout ratio 47.2%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 0.67 USD · Payout ratio 950.0%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 0.67 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 0.67 USD · Payout ratio 47.2%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 0.67 USD · Payout ratio 83.1%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 0.67 USD · Payout ratio not available
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 0.67 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 0.67 USD · Payout ratio 28.9%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 0.67 USD · Payout ratio 28.8%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 0.67 USD · Payout ratio 39.6%
Ratio
76%47%950%47%83%29%29%40%
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 402.1B USD · Net income 1.8B USD · Net margin 0.4%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +5.4% vs. the same quarter a year earlier; grown for at least 16 quarters in a row.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
3.7%
Fiscal year 2025: 1.9%
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Dec 31, 2025 402.1B USD + year to date to Sep 30, 2026 314.9B USD − same period a year earlier to Sep 30, 2025 296.4B USD = 420.6B USD
Net income: fiscal year to Dec 31, 2025 1.8B USD + year to date to Sep 30, 2026 8.1B USD − same period a year earlier to Sep 30, 2025 −1.2B USD = 11.0B USD
Operating cash flow: fiscal year to Dec 31, 2025 10.6B USD + year to date to Sep 30, 2026 15.3B USD − same period a year earlier to Sep 30, 2025 7.2B USD = 18.7B USD
Capital expenditure: fiscal year to Dec 31, 2025 2.8B USD + year to date to Sep 30, 2026 2.4B USD − same period a year earlier to Sep 30, 2025 2.0B USD = 3.1B USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
108.4B
+5.4%
2.2B
2.0%
Apr–Jun 26
106.1B
+7.3%
3.0B
2.8%
Jan–Mar 26
100.4B
+6.2%
2.9B
2.9%
Oct–Dec 25*
105.7B
+8.2%
2.9B
2.8%
Jul–Sep 25
102.9B
+7.8%
−4.0B
−3.9%
Apr–Jun 25
98.9B
+8.4%
1.0B
1.0%
Jan–Mar 25
94.6B
+7.0%
1.8B
1.9%
Oct–Dec 24*
97.7B
+4.2%
1.6B
1.7%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
As of: 12 months to Sep 30, 2026, filed on Nov 4, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is backed by cash; interest is thinly covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
6.16x
0.81.0
backed from 1.0 · 3 years: 2.26x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
1.5x
25
well covered from 5 · 3 years: 3.1x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2025 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years one loss year and no year with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
1 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
0 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
3.9 percentage points
from −0.3% to 3.6%
20162025Net margin by fiscal yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2025
+7.8%
0.4%
2024
+4.2%
1.2%
2023
+10.9%
2.3%
2022
+10.4%
1.3%
2021
+8.7%
2.7%
2020
+4.6%
2.7%
2019
+32.0%
2.6%
2018
+5.3%
−0.3%
2017
+4.1%
3.6%
2016
+15.8%
3.0%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2016–2025 · Source: SEC filings
Since when has today’s status held?
Check status by fiscal year
Check status by fiscal yearPoints of the four quality checks without price data by fiscal year: earlier years recalculated as of the filing date of their annual report with the figures known then, the latest year with today’s status. This shows since when today’s status has held.Example: Quality 7 of 8 in the annual reports 2022 to 2025, still 6 of 8 in 2021 → since fiscal year 2022.More in the Academy: Guide fundamental analysis
Quality: 2 of 7 criteria in every annual report since 2024; Financial strength in fiscal year 2025: 5 of 6 (prior year 4 of 6).
Quality2 of 7since FY 2024 · before that 3 of 7
Growth5 of 7since FY 2024 · before that 6 of 6
Dividend6 of 7since FY 2024 · before that 7 of 7
Financial strength5 of 6since FY 2025 · before that 4 of 6
More depth
Criteria met by fiscal year (met/with data)
Check
2021
2022
2023
2024
2025
Quality
2/7
2/7
3/7
2/7
2/7
Growth
5/6
5/7
6/6
5/7
5/7
Dividend
7/7
6/7
7/7
6/7
6/7
Financial strength
4/6
4/6
4/6
4/6
5/6
Fiscal year 2025 with today’s status of the checks without price data (for accounts, the badges above also count P/E/PEG and dividend yield).
Earlier years as of the filing date of their annual report: FY 2024 on Feb 12, 2025, FY 2023 on Feb 7, 2024, FY 2022 on Feb 8, 2023, FY 2021 on Feb 9, 2022.
Recalculated only with SEC filings up to the respective filing date – later corrections are left out. Without price-based criteria (P/E, dividend yield); criteria without data do not count.
As of annual reports 2021–2025 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2025
Of 100 USD of revenue, 1.2 USD operating income and 0.4 USD net income remained.
Revenue402.1B USD · 100%Operating income4.7B USD · 1%Cost of revenue and operating expenses397.4B USD · 99%Net income1.8B USD · 0%Taxes408.0M USD · 0%Interest & other (net)2.5B USD · 1%
Money flow as a table
Fiscal year 2025, amounts in USD, share of revenue
Item
Amount
of revenue
Revenue
402.1B USD
100.0%
Operating income
4.7B USD
1.2%
Cost of revenue and operating expenses
397.4B USD
98.8%
Net income
1.8B USD
0.4%
Taxes
408.0M USD
0.1%
Interest & other (net)
2.5B USD
0.6%
Taxes, interest and other items are not available separately in the SEC data; they are combined as the difference.
Margins
The operating margin fell in 5 years from 5.2% to 1.2%.
Gross marginOperating marginNet margin
0%5%10%15%20%
2016Fiscal year 2016: Gross margin 16.3% · Operating margin 5.8% · Net margin 3.0%
2017Fiscal year 2017: Gross margin 15.4% · Operating margin 5.2% · Net margin 3.6%
2018Fiscal year 2018: Gross margin not available · Operating margin 2.1% · Net margin −0.3%
2019Fiscal year 2019: Gross margin not available · Operating margin 4.7% · Net margin 2.6%
2020Fiscal year 2020: Gross margin not available · Operating margin 5.2% · Net margin 2.7%
2021Fiscal year 2021: Gross margin not available · Operating margin 4.5% · Net margin 2.7%
2022Fiscal year 2022: Gross margin not available · Operating margin 2.4% · Net margin 1.3%
2023Fiscal year 2023: Gross margin not available · Operating margin 3.8% · Net margin 2.3%
2024Fiscal year 2024: Gross margin not available · Operating margin 2.3% · Net margin 1.2%
2025Fiscal year 2025: Gross margin not available · Operating margin 1.2% · Net margin 0.4%
Returns
Return on equity fell in 5 years from 10.3% to 2.4%.
Return on equityReturn on assets
0%5%10%15%20%
2016Fiscal year 2016: Return on equity 14.4% · Return on assets 5.6%
2017Fiscal year 2017: Return on equity 17.6% · Return on assets 7.0%
2018Fiscal year 2018: Return on equity −1.0% · Return on assets −0.3%
2019Fiscal year 2019: Return on equity 10.4% · Return on assets 3.0%
2020Fiscal year 2020: Return on equity 10.3% · Return on assets 3.1%
2021Fiscal year 2021: Return on equity 10.5% · Return on assets 3.4%
2022Fiscal year 2022: Return on equity 5.8% · Return on assets 1.8%
2023Fiscal year 2023: Return on equity 10.9% · Return on assets 3.3%
2024Fiscal year 2024: Return on equity 6.1% · Return on assets 1.8%
2025Fiscal year 2025: Return on equity 2.4% · Return on assets 0.7%
Equity and long-term debt
The equity ratio stayed roughly the same in 5 years (29.7%).
EquityLong-term debtin USDLong-term debt, depending on the filing, includes the current portion or leases. Definition changes: some years use a different debt tag.
2016Fiscal year 2016: Operating cash flow 10.1B USD · Capital expenditure 2.2B USD · Free cash flow 7.8B USD
2017Fiscal year 2017: Operating cash flow 8.0B USD · Capital expenditure 1.9B USD · Free cash flow 6.1B USD
2018Fiscal year 2018: Operating cash flow 8.9B USD · Capital expenditure 2.0B USD · Free cash flow 6.8B USD
2019Fiscal year 2019: Operating cash flow 12.8B USD · Capital expenditure 2.5B USD · Free cash flow 10.4B USD
2020Fiscal year 2020: Operating cash flow 15.9B USD · Capital expenditure 2.4B USD · Free cash flow 13.4B USD
2021Fiscal year 2021: Operating cash flow 18.3B USD · Capital expenditure 2.5B USD · Free cash flow 15.7B USD
2022Fiscal year 2022: Operating cash flow 16.2B USD · Capital expenditure 2.7B USD · Free cash flow 13.5B USD
2023Fiscal year 2023: Operating cash flow 13.4B USD · Capital expenditure 3.0B USD · Free cash flow 10.4B USD
2024Fiscal year 2024: Operating cash flow 9.1B USD · Capital expenditure 2.8B USD · Free cash flow 6.3B USD
2025Fiscal year 2025: Operating cash flow 10.6B USD · Capital expenditure 2.8B USD · Free cash flow 7.8B USD
Share count
The share count fell in 5 years by 3.3% (mostly through share repurchases).
Diluted share count
0500M1B1.5B
2016Fiscal year 2016: Diluted share count 1.1B
2017Fiscal year 2017: Diluted share count 1.0B
2018Fiscal year 2018: Diluted share count 1.0B
2019Fiscal year 2019: Diluted share count 1.3B
2020Fiscal year 2020: Diluted share count 1.3B
2021Fiscal year 2021: Diluted share count 1.3B
2022Fiscal year 2022: Diluted share count 1.3B
2023Fiscal year 2023: Diluted share count 1.3B
2024Fiscal year 2024: Diluted share count 1.3B
2025Fiscal year 2025: Diluted share count 1.3B
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Earnings per share
Earnings per share fell in 5 years from 5.46 USD to 1.39 USD.
CVSUSD per share
02.004.006.008.00
2016Fiscal year 2016: CVS 4.90 USD
2017Fiscal year 2017: CVS 6.44 USD
2018Fiscal year 2018: CVS −0.57 USD
2019Fiscal year 2019: CVS 5.08 USD
2020Fiscal year 2020: CVS 5.46 USD
2021Fiscal year 2021: CVS 5.95 USD
2022Fiscal year 2022: CVS 3.14 USD
2023Fiscal year 2023: CVS 6.47 USD
2024Fiscal year 2024: CVS 3.66 USD
2025Fiscal year 2025: CVS 1.39 USD
Revenue
Revenue rose in 5 years from 268.7B USD to 402.1B USD.
CVSin USD
0200B400B600B
2016Fiscal year 2016: CVS 177.5B USD
2017Fiscal year 2017: CVS 184.8B USD
2018Fiscal year 2018: CVS 194.6B USD
2019Fiscal year 2019: CVS 256.8B USD
2020Fiscal year 2020: CVS 268.7B USD
2021Fiscal year 2021: CVS 292.1B USD
2022Fiscal year 2022: CVS 322.5B USD
2023Fiscal year 2023: CVS 357.8B USD
2024Fiscal year 2024: CVS 372.8B USD
2025Fiscal year 2025: CVS 402.1B USD
Net margin
The net margin fell in 5 years from 2.7% to 0.4%.
CVSSector today 13.9%Mark in the latest year: today’s median of the Health Care sector as in the sector comparison (each latest fiscal year). We do not have earlier medians.
0%5%10%15%
2016Fiscal year 2016: CVS 3.0%
2017Fiscal year 2017: CVS 3.6%
2018Fiscal year 2018: CVS −0.3%
2019Fiscal year 2019: CVS 2.6%
2020Fiscal year 2020: CVS 2.7%
2021Fiscal year 2021: CVS 2.7%
2022Fiscal year 2022: CVS 1.3%
2023Fiscal year 2023: CVS 2.3%
2024Fiscal year 2024: CVS 1.2%
2025Fiscal year 2025: CVS 0.4% · Sector today 13.9%
Source: SEC filings, fiscal years up to Dec 31, 2025. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 2.3x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
at least 10
as far as the data goes
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
+5.9%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
2.3x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2020 2.00 USD → fiscal year 2025 2.66 USD = +5.9% per year
Free cash flow per share 6.14 USD ÷ dividend per share 2.66 USD = 2.3x
Years without a cut: in a row up to fiscal year 2025, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is above its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
2.66USD · Fiscal year 2025
Dividend growth per year
3 y+6.5%5 y+5.9%10 y+6.6%
Payout ratio
of earnings191%of free cash flow44%
To shareholders (5 years)
24.0B USD36% through repurchases
Share count over 5 years
−3.3%fewer shares – each share is a larger stake
Dividend per share
The dividend per share rose in 5 years from 2.00 USD to 2.66 USD.
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
01.002.003.00
2016Fiscal year 2016: Dividend per share 1.70 USD
2017Fiscal year 2017: Dividend per share 2.00 USD
2018Fiscal year 2018: Dividend per share 2.00 USD
2019Fiscal year 2019: Dividend per share 2.00 USD
2020Fiscal year 2020: Dividend per share 2.00 USD
2021Fiscal year 2021: Dividend per share 2.00 USD
2022Fiscal year 2022: Dividend per share 2.20 USD
2023Fiscal year 2023: Dividend per share 2.42 USD
2024Fiscal year 2024: Dividend per share 2.66 USD
2025Fiscal year 2025: Dividend per share 2.66 USD
Payout ratios
The payout ratio rose in 5 years from 36.6% to 191.4%.
Payout ratio (earnings)Payout ratio (free cash flow)
0%50%100%150%200%
2016Fiscal year 2016: Payout ratio (earnings) 34.7% · Payout ratio (free cash flow) 23.5%
2017Fiscal year 2017: Payout ratio (earnings) 31.1% · Payout ratio (free cash flow) 33.7%
2018Fiscal year 2018: Payout ratio (earnings) not available · Payout ratio (free cash flow) 29.8%
2019Fiscal year 2019: Payout ratio (earnings) 39.4% · Payout ratio (free cash flow) 25.1%
2020Fiscal year 2020: Payout ratio (earnings) 36.6% · Payout ratio (free cash flow) 19.5%
2021Fiscal year 2021: Payout ratio (earnings) 33.6% · Payout ratio (free cash flow) 16.7%
2022Fiscal year 2022: Payout ratio (earnings) 70.1% · Payout ratio (free cash flow) 21.6%
2023Fiscal year 2023: Payout ratio (earnings) 37.4% · Payout ratio (free cash flow) 30.1%
2024Fiscal year 2024: Payout ratio (earnings) 72.7% · Payout ratio (free cash flow) 53.3%
2025Fiscal year 2025: Payout ratio (earnings) 191.4% · Payout ratio (free cash flow) 43.5%
What goes back to shareholders
Over 5 years, 24.0B USD went back to shareholders, 36% of it through share repurchases. That is 45% of the free cash flow of those years.
2016Fiscal year 2016: Dividends paid 1.8B USD · Share repurchases 4.5B USD · New shares issued (including employee plans) not available · Free cash flow 7.8B USD
2017Fiscal year 2017: Dividends paid 2.0B USD · Share repurchases 4.4B USD · New shares issued (including employee plans) not available · Free cash flow 6.1B USD
2018Fiscal year 2018: Dividends paid 2.0B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 6.8B USD
2019Fiscal year 2019: Dividends paid 2.6B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 10.4B USD
2020Fiscal year 2020: Dividends paid 2.6B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 13.4B USD
2021Fiscal year 2021: Dividends paid 2.6B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 15.7B USD
2022Fiscal year 2022: Dividends paid 2.9B USD · Share repurchases 3.5B USD · New shares issued (including employee plans) not available · Free cash flow 13.5B USD
2023Fiscal year 2023: Dividends paid 3.1B USD · Share repurchases 2.0B USD · New shares issued (including employee plans) not available · Free cash flow 10.4B USD
2024Fiscal year 2024: Dividends paid 3.4B USD · Share repurchases 3.0B USD · New shares issued (including employee plans) not available · Free cash flow 6.3B USD
2025Fiscal year 2025: Dividends paid 3.4B USD · Share repurchases 0.0 USD · New shares issued (including employee plans) not available · Free cash flow 7.8B USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
CVS Health next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison CVS, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+8.4%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 8.4% per year on average, but more slowly than the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light red: shrinking
−24.4%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: −23.9% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it fell by 24.4% per year on average. The median company in the sector reached +5.5% per year.
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 0.44 USD remained as profit – less than the median company in the sector (13.9%). Five years ago the margin was 2.7%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light yellow: higher than sector
0.71latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? For every 1 USD of equity there is 0.71 USD of financial debt – more than the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light red: above earnings
191%Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? The payout was higher than the earnings per share; it is paid from cash flow, from reserves or with new debt. Median company in the sector: 56%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light yellow: 1 loss year
9 of 10fiscal years with a profit
What does this mean? In 9 of the last 10 fiscal years the bottom line showed a profit. One year ended with a loss.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
402.1B USD
Revenue vs. prior year
+7.8%
Net income (FY)
1.8B USD
Net income vs. prior year
−61.7%
EPS (FY)
1.39 USD
Superinvestors holding
2 of 26
Fiscal year to Dec 31, 2025 · 10-K filed Feb 10, 2026 · Balance sheet Sep 30, 2026 (filed Nov 4, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
402.1B
1.8B
0.4%
1.39
2.66
191%
2024
Dec 31, 2024
372.8B
4.6B
1.2%
3.66
2.66
73%
2023
Dec 31, 2023
357.8B
8.3B
2.3%
6.47
2.42
37%
2022
Dec 31, 2022
322.5B
4.1B
1.3%
3.14
2.20
70%
2021
Dec 31, 2021
292.1B
7.9B
2.7%
5.95
2.00
34%
2020
Dec 31, 2020
268.7B
7.2B
2.7%
5.46
2.00
37%
2019
Dec 31, 2019
256.8B
6.6B
2.6%
5.08
2.00
39%
2018
Dec 31, 2018
194.6B
−594.0M
−0.3%
−0.57
2.00
–
2017
Dec 31, 2017
184.8B
6.6B
3.6%
6.44
2.00
31%
2016
Dec 31, 2016
177.5B
5.3B
3.0%
4.90
1.70
35%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
108.4B
2.2B
2.0%
1.68
0.67
40%
Q2/26
Jun 30, 2026
106.1B
3.0B
2.8%
2.31
0.67
29%
Q1/26
Mar 31, 2026
100.4B
2.9B
2.9%
2.30
0.67
29%
Q4/25*
Dec 31, 2025
105.7B
2.9B
2.8%
–
0.67
–
Q3/25
Sep 30, 2025
102.9B
−4.0B
−3.9%
−3.13
0.67
–
Q2/25
Jun 30, 2025
98.9B
1.0B
1.0%
0.80
0.67
83%
Q1/25
Mar 31, 2025
94.6B
1.8B
1.9%
1.41
0.67
47%
Q4/24*
Dec 31, 2024
97.7B
1.6B
1.7%
–
0.67
–
Q3/24
Sep 30, 2024
95.4B
87.0M
0.1%
0.07
0.67
950%
Q2/24
Jun 30, 2024
91.2B
1.8B
1.9%
1.41
0.67
47%
Q1/24
Mar 31, 2024
88.4B
1.1B
1.3%
0.88
0.67
76%
Q4/23*
Dec 31, 2023
93.8B
2.0B
2.2%
–
0.61
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
May 21, 2026Robbins LarryDirectorOpen-market sale370,462 shares · $34.6M · SEC
May 20, 2026Robbins LarryDirectorOpen-market sale800 shares · $77.0K · SEC
May 20, 2026Robbins LarryDirectorOpen-market sale66,881 shares · $6.4M · SEC
May 20, 2026Robbins LarryDirectorOpen-market sale152,691 shares · $14.5M · SEC
May 20, 2026Robbins LarryDirectorOpen-market sale797,628 shares · $74.6M · SEC
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold CVS Health?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Sold out in the latest quarter: Andreas Halvorsen, Paul Tudor Jones, Steve Cohen.
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score -35
Price vs. EMA 50-15
Price vs. EMA 200-15
EMA 50 vs. EMA 200+20
ADX (trend strength)+0
Highs and lows-10
Price change 60 days-15
Volatility and trend strength
ADX 14 (trend strength)moderate (20 to 25)
Price change 60 daysdown
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.